Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multi-operations for non-small cell lung cancer].

Y Wu1, Z Huang, T Rong

  • 1Cancer Hospital, Sun Yat-sen University of Medical Sciences, Guangzhou.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|March 1, 1997
PubMed
Summary

Multi-operations can improve survival for advanced non-small cell lung cancer (NSCLC) patients with recurrent or metastatic disease. However, subsequent surgeries increase complication risks, necessitating careful pulmonary function assessment and monitoring for respiratory failure and hemorrhage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026
Same author

First Observation of the B[over ¯]_{s}^{0}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} Decay and Evidence for the B[over ¯]^{0}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} Decay.

Physical review letters·2026

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Cancer Research

Context:

  • Advanced non-small cell lung cancer (NSCLC) presents significant treatment challenges, particularly in recurrent, metastatic, or second primary disease settings.
  • Multi-operation strategies are explored to improve survival outcomes in these complex cases.
  • Evaluating the efficacy and safety of repeated surgical interventions is crucial for optimizing patient management.

Purpose:

  • To present the experiences and outcomes of multi-operations in patients with advanced non-small cell lung cancer.
  • To analyze the survival rates and postoperative complications associated with repeated surgical procedures for NSCLC.
  • To assess the effectiveness of multi-operations in improving survival for recurrent, metastatic, or second primary NSCLC.

Summary:

Related Experiment Videos

  • Fifty-six operations were performed on 26 patients with advanced NSCLC. The first operation had a 3.8% complication rate and 1-, 3-, and 5-year survival rates of 83.5%, 58.4%, and 35.7% respectively.
  • Subsequent operations showed increased complication rates (26.9% for the second operation) and operative mortality (11.5%), with significantly reduced survival rates (median survival of 15 months after the second operation).
  • Despite increased risks, multi-operations demonstrated continued effectiveness for recurrent, metastatic, or second primary lung cancer, though simple spirometry was insufficient for pulmonary function evaluation.

Impact:

  • Multi-operations can be a viable strategy for extending survival in select advanced NSCLC patients.
  • Highlights the increased risks associated with repeated surgeries, emphasizing the need for careful patient selection and risk management.
  • Underscores the limitations of standard pulmonary function tests and the critical importance of monitoring for specific complications like respiratory failure and hemorrhage.